Pancreatic cancer

The D'20 peptide inhibits the cancer-causing enzyme MMP7. The image was prepared using DALEE and is not a scientific image

A new stable and selective inhibitor of a cancer-causing enzyme has been revealed in a new study

Researchers from the Hebrew University, the Weizmann Institute and the University of Tokyo have developed an innovative peptide that suppresses the activity of the MMP7 enzyme associated with cancer progression, with the potential for targeted therapies in aggressive cancers.
Pancreatic cancer. Illustration: depositphotos.com

A breakthrough in the study of deadly pancreatic cancer

Hebrew University researchers have discovered the molecular mechanism that allows pancreatic cancer to metastasize and become fatal. The discovery offers new treatment methods for the first time
Pancreatic cancer tumor with liver metastases. From Wikipedia

A new blood test will detect pancreatic cancer at an early stage

Prof. Ralph Steinman, discovers immune cells. Winner of the 2011 Hovel Medicine Award. From the NIH

The Patient Scientist / Catherine Harmon